[
  {
    "ts": null,
    "headline": "Growing Biosimilars Business, New Partnerships Support ABT Stock",
    "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
    "url": "https://finnhub.io/api/news?id=63f4c8306a24657305e688044a6114b4eb366d119cc0fbeda61b6b070c4c8879",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735307160,
      "headline": "Growing Biosimilars Business, New Partnerships Support ABT Stock",
      "id": 132175051,
      "image": "https://media.zenfs.com/en/zacks.com/769ea4b39e167b1ab7916652e1917be6",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
      "url": "https://finnhub.io/api/news?id=63f4c8306a24657305e688044a6114b4eb366d119cc0fbeda61b6b070c4c8879"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company",
    "summary": "Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...",
    "url": "https://finnhub.io/api/news?id=60ba9ca357d80fdf3ee7a6eefb2fca3de80d64a35f3e9e762b42a55882f7f8a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735304418,
      "headline": "Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company",
      "id": 132175054,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...",
      "url": "https://finnhub.io/api/news?id=60ba9ca357d80fdf3ee7a6eefb2fca3de80d64a35f3e9e762b42a55882f7f8a1"
    }
  }
]